These look like great picks to buy in May before you go away.
News & Analysis: Emergent BioSolutions
A new government contract for smallpox vaccine, ACAM2000, is still in the works.
These three biotech stocks could be prime comeback candidates.
Shares drop after the company reports first-quarter results that missed the mark.
EBS earnings call for the period ending March 31, 2019.
Newly acquired products should help the bioterrorism specialist hit its goal.
EBS earnings call for the period ending December 31, 2018.
The bioterrorism-response company expands externally.
EBS earnings call for the period ending September 30, 2018.
Timing issues in the first quarter are a thing of the past.